Skip to main content

CORRECTION article

Front. Pharmacol., 14 December 2023
Sec. Pharmacology of Anti-Cancer Drugs
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1345663

Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy

This article is a correction to:

  1. Advances in the roles of glycyrrhizic acid in cancer therapy

    1. Read original article
Yuqian Zhang&#x;Yuqian Zhang1†Zixuan Sheng&#x;Zixuan Sheng1†Jing XiaoJing Xiao1Yang LiYang Li1Jie HuangJie Huang1Jinjing Jia,Jinjing Jia1,2Xiansi Zeng, Xiansi Zeng1,3*Li Li, Li Li1,2*
  • 1Research Center of Neuroscience, Jiaxing University Medical College, Jiaxing, China
  • 2Department of Physiology, Jiaxing University Medical College, Jiaxing, China
  • 3Department of Biochemistry and Molecular Biology, Jiaxing University Medical College, Jiaxing, China

A Corrigendum on
Advances in the roles of glycyrrhizic acid in cancer therapy

by Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J, Zeng X and Li L (2023). Front. Pharmacol. 14:1265172. doi: 10.3389/fphar.2023.1265172

In the published article, there was an error in Affiliations 1 and 2. Instead of “1Research Center of Neuroscience, Jiaxing, China; 2Department of Physiology, Jiaxing, China,” it should be “1Research Center of Neuroscience, Jiaxing University Medical College, Jiaxing, China; 2Department of Physiology, Jiaxing University Medical College, Jiaxing, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer, glycyrrhizic acid, anti-cancer, side effects, mechanisms

Citation: Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J, Zeng X and Li L (2023) Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy. Front. Pharmacol. 14:1345663. doi: 10.3389/fphar.2023.1345663

Received: 28 November 2023; Accepted: 07 December 2023;
Published: 14 December 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Zhang, Sheng, Xiao, Li, Huang, Jia, Zeng and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiansi Zeng, enhzLTIwMDVAdmlwLjE2My5jb20=; Li Li, TGlseTc1ODhAMTYzLmNvbQ==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.